Correlation analysis showed a significant negative correlation between tumor CD8+ T cells and ILC2s in human CRC (Fig. 5A), and between Th1 cells and ILC2s (Fig. 5B), suggesting that CRCs with a higher ILC2 frequency may have impaired anti-tumor T cell responses and worse prognosis. This evidence concerns the gene CD8A and neoplasm.